第一部分 奋斗历程 1
一、沈倍奋院士自述 3
二、沈倍奋院士简介 5
第二部分 学术贡献 7
一、沈倍奋院士的学术成就与学术思想 9
二、沈倍奋院士的主要学术论文 10
（一）人类白细胞分化抗原、抗体及其应用 10
人外周血淋巴细胞表面SRBC受体的研究 10
Ⅰ．SRBC受体的分离和性质 10
人外周血淋巴细胞表面SRBC受体的研究 16
Ⅱ．亲和层析法提纯受体及其性质的研究 16
免疫毒素抑制靶细胞蛋白质合成的动力学研究 21
抗人T细胞单克隆抗体与蓖麻毒素结合物的制备及其细胞毒性质 25
免疫毒素清除人骨髓中克隆化白血病细胞的研究 26
CD9、CD10单克隆抗体免疫毒素对白血病细胞的清除率及对造血细胞的影响 31
抗人白细胞分化抗原单克隆抗体免疫毒素在自体骨髓移植中的应用 36
抗T免疫毒素用于异基因骨髓移植的实验研究及初步应用 40
氨甲蝶呤－人血清白蛋白－单抗79结合物的制备及其体外细胞毒作用 46
基因分析在急性白血病分型中应用的基础研究 52
（二）白细胞介素6和白细胞介素6受体的研究 58
可溶性白细胞介素6受体β亚基拮抗IL-6信号的研究 58
可溶性gp130和gp130反义核酸对IL-6诱导的靶基因启动子活性的影响 65
多发性骨髓瘤和白血病细胞中白细胞介素-6激活的核因子活性比较 71
IL-6信号转导与转录激活子活性研究 77
hIL-6·hIL-6Rα·gp130三元复合物的结构预测 84
人白介素6与其受体结合特定结构域的预测 91
人骨髓瘤细胞中两条IL-6信号转导途径的相互调控方式 98
Effects of STAT3 Antisense RNA on IL-6-induced Differentiation and Growth Arrest of M1 Leukemia Cells 104
Proteomic Analysis of Interleukin 6-induced Differentiation in Mouse Myeloid Leukemia Cells 109
The Design of Antagonist Peptide of hIL-6 Based on the Binding Epitope of hIL-6 by Computer-aided Molecular Modeling 119
（三）抗体工程研究 129
用噬菌体随机肽库确定抗TNF单抗识别的表位 129
Humanization of an Anti-human TNF-α Antibody by Variable Region Resurfacing with the Aid of Molecular Modeling 135
Identification of Binding Epitope of a Monoclonal Antibody （Z12） Against Human TNF-α Using Computer Modeling and Deletion Mutant Technique 143
Rational Design of Potent Mimic Peptide Derived from Monoclonal Antibody: Antibody Mimic Design 151
De Novo Design TNF-α Antagonistic Peptide Based on the Complex Structure of TNF-α with its Neutralizing Monoclonal Antibody Z12 158
A Novel Human scFv Fragment Against TNF-α from de novo Design Method 165
A Novel Domain Antibody Rationally Designed Against TNF-α Using Variable Region of Human Heavy Chain Antibody as Scaffolds to Display Antagonistic Peptides 176
Structured to Reduce the Mitogenicity of Anti-CD3 Antibody Based on Computer-guided Molecular Design 185
Novel Anti-CD20 Antibody TGLA with Enhanced Antibody-dependent Cell-mediated Cytotoxicity Mediates Potent Anti-lymphoma Activity 199
Structural Basis of LaDR5, a Novel Agonistic Anti-death Receptor 5 （DR5） Monoclonal Antibody, to Inhibit DR5/TRAIL Complex Formation 208
An Efficient and Targeted Gene Integration System for High-level Antibody Expression 221
Design and Assembly of Anti-CD16 ScFv Antibody with Two Different Linker Peptides 233
Structure-based Affinity Maturation of a Chimeric Anti-ricin Antibody C4C13 243
Affinity Maturation of AntiHER2 Monoclonal Antibody MIL5 Using an Epitope-specific Synthetic Phage Library by Computational Design 252
（四）免疫耐受、自身免疫、细胞信号转导 263
Lineage-dependent NF-kB Activation Contributes to the Resistance of Human Macrophages to Apoptosis Lineage-dependent NF-kB Activation Contributes to the Resistance of Human 263
Active Tolerance Induction and Prevention of Autoimmune Diabetes by Immunogene Therapy Using Recombinant Adenoassociated Virus Expressing Glutamic Acid Decarboxylase 65 Peptide GAD500-585 Lineage-dependent NF-kB Activation Contributes to the Resistance of Human 271
Novel Strategies for Inhibition of the p38 MAPK Pathway 285
Autoantibody Profiling of Chinese Patients with Autoimmune Hepatitis Using Immunoproteomic Analysis 298
MEKK3 Overexpression Contributes to the Hyperresponsiveness of IL-12 Overproducing Cells and CD4+ T Conventional Cells in Nonobese Diabetic Mice 308
Defective Anchoring of JNK1 in the Cytoplasm by MKK7 in Jurkat Cells is Associated with Resistance to Fas-mediated Apoptosis 322
Receptor for Activated C Kinase 1 Promotes Hepatocellular Carcinoma Growth by Enhancing Mitogen-Activated Protein Kinase Kinase 7 Activity 335
T Cell Ig Mucin-3 Promotes Homeostasis of Sepsis by Negatively Regulating the TLR Response 347
Complement C5a Regulates IL-17 by Affecting the Crosstalk between DC and γδT Cells in CLP-induced Sepsis 364
Identification of Conformational Core Epitope Lys68 in C5a Based on the 3-D Modeling Complex C5a and Its Functional Antibody F20 374
Blockade of Complement Activation Product C5a Activity Using Specific Antibody Attenuates Intestinal Damage in Trinitrobenzene Sulfonic Acid Induced Model of Colitis 383
Regulation of IL-8 Production by Complement-activated Product, C5a, in vitro and in vivo during Sepsis 396
（五）其他 406
抗尿激酶单克隆抗体识别相应抗原决定簇的研究 406
单克隆抗体亲和柱纯化尿激酶的研究 410
重组人粒细胞巨噬细胞集落刺激因子的研究 411
cDNA Cloning and Function Analysis of Two Novel Erythroid Differentiation Related Genes 416
Initial Function Analysis of a Novel Erythroid Differentiation Related Gene EDRF1 422
Microarray-based Differential Expression Monitoring of 79 Novel Genes in Differentiated K562 Cells 429
J2 Prolongs the Corneal Allograft Survival Through Inhibition of the CD4+ T Cell-mediated Response in Vivo 437
3D Structure of Human FK506-binding Protein 52: Implications for the Assembly of the Glucocorticoid Receptor/Hsp90/immunophilin Heterocomplex 447
利用荧光极化技术在均相系统内建立基于Bcl-2/Bak作用模式的高通量药物筛选体系 455
A Novel BLyS Antagonist Peptide Designed Based on the 3-D Complex Structure of BCMA and BLyS 461
Proteomic Analysis of Ubiquitin-proteasome Effects: Insight into the Function of Eukaryotic Initiation Factor 5A 467
Identify the Key Amino Acid of BAFF Binding with TACI 481
三、沈倍奋院士的主要著作 491
细胞调控的探索 491
分子文库 494
重组抗体 501
生物恐怖防御 505
公众应对恐怖事件常识 511
四、沈倍奋院士学术年表 517
沈倍奋院士中文论文目录 517
沈倍奋院士英文论文目录 547
沈倍奋院士著作目录 562
沈倍奋院士科研成果目录 563
沈倍奋院士发明专利目录 564
第三部分 大师风范 567
前行的灯塔人生的导师 569
师恩难忘 570
踏实做事 真实做人 572
学无止境 天道酬勤 574
第四部分 社会影响 575
柔弱的执着——记中国工程院女院士、国家“863”计划生物技术领域专家委员会委员沈倍奋 577
沈倍奋：“这件事我们得赶紧做” 585
她用生物导弹向白血病进攻——访军事医学科学院副研究员沈倍奋 587
科学品质和质朴人生——专访中国工程院院士沈倍奋 589
三分命运 七分拼搏——记新世纪巾帼发明家、著名免疫学家沈倍奋 592
第五部分 人生风采 595
成长历程 597
学术活动 599
桃李满园 607
实至名归 608
幸福生活 610
院士近照 612